# AMG 334 20160172 Pediatric Migraine PK Study.

> **NCT03499119** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 53 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** AMG 334 Dose 1
- **DRUG:** AMG 334 Dose 2
- **DRUG:** AMG 334 Dose 3

## Key facts

- **NCT ID:** NCT03499119
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-04
- **Primary completion:** 2021-11-23
- **Final completion:** 2021-11-23
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2024-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03499119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03499119, "AMG 334 20160172 Pediatric Migraine PK Study.". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03499119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*